特発性血小板減少性紫斑病(免疫性血小板減少性紫斑病)(Idiopathic Thrombocytopenic Purpura)治療薬市場2015:上市品分析、API(原薬)メーカー分析、世界市場規模

調査会社DelveInsight社が発行したリサーチレポート(データ管理コード:DII2015API316)
◆英語タイトル:Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura)-API Insights, 2015
◆発行会社/調査会社:DelveInsight
◆商品コード:DII2015API316
◆発行日:2015年版(※最新版はお問い合わせください)
◆調査対象地域:グローバル
◆産業分野:製薬
◆ページ数:約60
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール(納品まで約3営業日)
◆販売価格オプション(消費税別)
Single User(1名使用)USD1,250 ⇒換算¥136,250見積依頼/購入/質問フォーム
Site Price(同一国内共有可)USD2,500 ⇒換算¥272,500見積依頼/購入/質問フォーム
Enterprise Price(複数国内共有可)USD4,000 ⇒換算¥436,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
DelveInsight社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[特発性血小板減少性紫斑病(免疫性血小板減少性紫斑病)(Idiopathic Thrombocytopenic Purpura)治療薬市場2015:上市品分析、API(原薬)メーカー分析、世界市場規模]についてメールでお問い合わせはこちら
当調査レポートでは、特発性血小板減少性紫斑病(免疫性血小板減少性紫斑病)(Idiopathic Thrombocytopenic Purpura)治療薬市場について調査・分析し、申請タイプ別上市品の詳細、市販状況別上市品の詳細、APIメーカーの分析、世界販売量予測、上市品別の市場情報、中止された医薬品情報などを以下の構成でお届けいたします。※本レポートはご注文を頂いてから、最新データに更新して納品しているため、正確なページ数を明記しておりません。

・上市品の分析
-アプリケーション(申請)タイプ別上市品の詳細
-マーケティング(市販)状況別上市品の詳細
-特許権存続期間別上市品の分析
・API(医薬品有効成分)メーカーの分析
 -米国DMF(ドラッグマスターファイル)状況別APIメーカー
 -米国DMF(ドラッグマスターファイル)状況別APIメーカー(Drug Specific)
・上市品の世界販売量予測データ
・上市品別の情報
 -医薬品の説明
 -医薬品の承認状況
 -グローバルAPIメーカー
 -特許及び独占権(Exclusivity)状況
 -企業概要
・中止された医薬品情報
*** レポート概要(サマリー)***

Summary

DelveInsight’s, Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura)-API Insights, 2015,report provides Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United States Drug Master File (USDMF) and Europe DMF filed by worldwide countries related to the drugs falling under Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura). The Report provides the India and China API Manufactures who are driving the current API Market. DelveInsight’s report also highlights the patent, patent exclusivity information and competitive landscape. The research analysis also presents the global sales forecasts data for the Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) drugs till 2016.
The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market.
India and China produce a large percentage of a majority of the APIs and intermediates produced in the world currently. The USFDA and EMA have strict guidelines for API manufacturing ‘Process Validation: General Principles and Practices’. While countries such as Japan and Singapore are signatories to the ICH Q7 regulation, India and China follow their national GMP guidelines. The efficiency and expertise of Asian contract manufacturers have positioned them in a very strategic space in the global pharmaceutical supply chain, with a vast majority of the APIs and intermediates being sourced from markets such as India and China.
Data Sources
The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts.Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


Scope

• A snapshot of the global Market therapeutics scenario for Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura).
• A review of the marketed products under prescription for Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura), regulatory information and marketing status.
• Coverage of global patent coverage and detailed commentaries on the US patent challenges.
• Graphical representation of investigational products for patent expiry and market exclusivities across the globe.
• Product profiles for marketed products for Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) with complete description of mechanism of action, therapeutic class, target, route(s) of administration and chemical details.
• Coverage of API Manufacturers for Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) drugs in the United States, Europe and Asian Regions with location details.
• Coverage of Regulatory filings in the US, Europe, and Asia specifically India and China for Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) drugs.
• Key discontinued Marketed products.
• Global Sales Figure from 2012-2016.


*** レポート目次(コンテンツ)***

Table of Contents
• Indication Overview
• Marketed Drugs Assessment
• Marketed Details of Drugs by Application Type
• Marketed Details of Drugs (NDA) by Marketing Status
• Marketed Details of Drugs by Patent Expiration Timeline
• The Active Pharmaceutical Ingredient (API) Manufacturers Assessment
• The API Manufacturers by the United States Drug Master File (US DMF) Status
• The API Manufacturers by the US DMF Status (Drug Specific)
• Drugs Market Data and Forecasted Sales Figures (2012-2016)
• Marketed Drugs Information
• Drugs Description
• Global Active Pharmaceutical Manufacturers
• Approval Status
• Patent and Exclusivity Details
• Company Overview
• Discontinued Drugs Information

List of Tables
Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) Therapeutic Market, US, Marketed Drugs by Application Type, 2015
Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) Therapeutic Market, US, Marketed Drugs by Marketing Status, 2015
Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) Therapeutic Market, US, (Year), 2015
Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) Marketed Drugs, API Manufacturers by US DMF Status, 2015
Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) Marketed Drugs, US DMF Status Drug Specific (Number), 2015
Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) Therapeutic Market, Global Sales (in million USD), 2015
Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) Marketed Drugs, API Manufacturers, Global, 2015
Discontinued Drugs for Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura), 2015


List of Figures
Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) Therapeutic Market, US, Marketed Drugs by Application Type (%), 2015
Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) Therapeutic Market, US, Marketed Drugs by Marketing Status (%), 2015
Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) Therapeutic Market, US, (Year), 2015
Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) Marketed Drugs, API Manufacturers by US DMF Status (%), 2015
Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) Marketed Drugs, US DMF Status Drug Specific (Number), 2015
Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) Therapeutic Market, Global Sales (in million USD), 2015
Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) Marketed Drugs, Patent/Exclusivity Expiry (Year), 2015


*** レポートのキーワード ***

特発性血小板減少性紫斑病(免疫性血小板減少性紫斑病)(Idiopathic Thrombocytopenic Purpura)、治療薬、上市品、API(原薬)メーカー、製薬、医薬品、市販、DMF(ドラッグマスターファイル)、承認、申請、市場規模

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
  • LS(LS Corp.)企業概要及び財務データ:韓国企業調査レポート
    韓国企業の概要及び財務データをまとめたレポートです。該当企業の設立日、住所、社員数、資本金、事業分野、連絡先、企業格付などの概要と、最近3年間の会計年度別貸借対照表(B/S)、損益計算書(P/L)、キャッシュ・フロー計算書(C/F)など財務データを調査しました。 韓国企業と取引する時、韓国に進出を検討する時、或いは韓国の競合企業を調べる時に、本データをご活用ください。追加のデータや詳しい情報が必要な場合は別途カスタムリサーチ(委託調査)サービスで対応致します。
  • 世界及び中国の塩化ステアリルトリメチルアンモニウム市場2017
    The 'Global and Chinese Stearyltrimethylammonium chloride Industry, 2012-2022 Market Research Report' is a professional and in-depth study on the current state of the global Stearyltrimethylammonium chloride industry with a focus on the Chinese market. The report provides key statistics on the marke …
  • Galderma S.A.:企業概要・戦略的SWOT分析
    Galderma S.A. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • 世界の人工リフトポンプ市場2015
    The Global Artificial Lift Pumps Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Artificial Lift Pumps industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structur …
  • 透明レーダー反射被膜の世界市場:販売動向2017
    Notes:Sales, means the sales volume of Transparent Radar Reflection Coating Revenue, means the sales value of Transparent Radar Reflection Coating This report studies sales (consumption) of Transparent Radar Reflection Coating in Global market, especially in United States, China, Europe and Japan, f …
  • 世界及び中国のリチウムビスオキサレ-トボラ-ト市場2016
    The 'Global and Chinese Lithium bis(oxalate)borate(LiBOB) Industry, 2011-2021 Market Research Report' is a professional and in-depth study on the current state of the global Lithium bis(oxalate)borate(LiBOB) industry with a focus on the Chinese market. The report provides key statistics on the marke …
  • レンガ及びブロック(建設材料)市場:イタリア
    This report is the result of Timetric’s extensive market research covering the bricks and blocks market in Italy. It contains detailed historic and forecast market value data for the bricks and blocks market and its categories (bricks and stone blocks), including data by domestic production, supply …
  • 世界のイノシトール市場2016
    Notes:Production, means the output of Inositol Revenue, means the sales value of Inositol This report studies Inositol in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with production, price, revenue and mar …
  • 消費者決済(支払)市場:フランス
    SummaryAs one of the largest consumer markets in Europe, France's highly developed payments system plays a key role in the economy. The macroeconomic woes facing the country have been instrumental in France's payments market witnessing minimal expansion in recent years. While growth in the market is …
  • ヨルダンの飼料添加物市場
    The report presents analysis of feed additives market in Jordan. Scope Brief country profile includes general information and main economic indicators and specifies business environment in Jordan Feed Additives market is analyzed by different parameters including domestic production and consumption. …
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(DII2015API316 )"特発性血小板減少性紫斑病(免疫性血小板減少性紫斑病)(Idiopathic Thrombocytopenic Purpura)治療薬市場2015:上市品分析、API(原薬)メーカー分析、世界市場規模" (英文:Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura)-API Insights, 2015)はDelveInsight社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。